FDA Approved: BREVIBLOC — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Brevibloc (esmolol hydrochloride) submitted by Baxter Healthcare Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Hypertension
• Supraventricular Tachycardia
• Tachyarrhythmia
• Tachycardia

Drugs mentioned

• Brevibloc (esmolol)

Snippet

SUPPL AP for BREVIBLOC (ESMOLOL HYDROCHLORIDE)